More than 13,500 people contracted COVID-19 in Connecticut between Aug. 1 and Oct. 5, according to the most recent state data ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

Through COVIDTests.gov, you can order up to four free COVID-19 tests per household, shipped at no cost to you. No payment or ...

The FDA has revised the EUA for Pemgarda (pemivibart), authorized for the preexposure prophylaxis of COVID-19.

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with some of these new viruses being transmitted onwards, a new study has ...

Headline inflation has fallen into the Reserve Bank's 2 to 3 per cent target for the first time in three years. Here's why it won't mean an early rate cut.

Dr. Murali Krishna Prasad Divi is the richest man in Hyderabad and built his fortune through Divi's Laboratories.

Elanco announced this week that its product Zenrelia has received approval from the FDA. Zenrelia is a once a day orally, ...

Swedesboro-based Wedgewood, the nation’s largest provider of compounded veterinary medications, announces the addition of molnupiravir to its formulary. Originally developed for human viral infections ...

The latest findings from the landmark PANORAMIC clinical trial indicate that the antiviral drug known as molnupiravir can offer some long-term benefits to vaccinated adults, the National Institute for ...